<VariationArchive RecordType="classified" VariationID="625740" VariationName="GRCh37/hg19 12q24.21(chr12:114791609-114793234)" VariationType="copy number loss" Accession="VCV000625740" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2019-04-21" MostRecentSubmission="2019-04-21">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="614044" VariationID="625740">
      <GeneList>
        <Gene Symbol="TBX5" FullName="T-box transcription factor 5" GeneID="6910" HGNC_ID="HGNC:11604" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>12q24.21</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="114353911" stop="114408442" display_start="114353911" display_stop="114408442" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="114791734" stop="114846246" display_start="114791734" display_stop="114846246" Strand="-" />
          </Location>
          <OMIM>601620</OMIM>
          <Haploinsufficiency last_evaluated="2020-07-29" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TBX5">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-07-29" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TBX5">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>GRCh37/hg19 12q24.21(chr12:114791609-114793234)</Name>
      <VariantType>copy number loss</VariantType>
      <Location>
        <CytogeneticLocation>12q24.21</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" innerStart="114791609" innerStop="114793234" display_start="114791609" display_stop="114793234" variantLength="1626" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.(?_114791609)_(114793234_?)del" Assembly="GRCh37">
            <Expression>NC_000012.11:g.(?_114791609)_(114793234_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="GRCh37/hg19 12q24.21(chr12:114791609-114793234) AND Holt-Oram syndrome" Accession="RCV000767748" Version="1">
        <ClassifiedConditionList TraitSetID="2174">
          <ClassifiedCondition DB="MedGen" ID="C0265264">Holt-Oram syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-11-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2018-11-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-04-21" MostRecentSubmission="2019-04-21">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="2174" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2051" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">TBX5-Related Holt-Oram Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Holt-Oram syndrome</ElementValue>
                <XRef ID="Holt-Oram+syndrome/3457" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007732" DB="MONDO" />
                <XRef ID="19092004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ventriculo-radial syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Atrio digital syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cardiac-limb syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Heart-hand syndrome, type 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">HOS 1</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HOS1</ElementValue>
                <XRef Type="MIM" ID="142900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">HOS</ElementValue>
                <XRef Type="MIM" ID="142900" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Holt-Oram syndrome (HOS) is characterized by upper-limb defects, congenital heart malformation, and cardiac conduction disease. Upper-limb malformations may be unilateral, bilateral/symmetric, or bilateral/asymmetric and can range from triphalangeal or absent thumb(s) to phocomelia. Other upper-limb malformations can include unequal arm length caused by aplasia or hypoplasia of the radius, fusion or anomalous development of the carpal and thenar bones, abnormal forearm pronation and supination, abnormal opposition of the thumb, sloping shoulders, and restriction of shoulder joint movement. An abnormal carpal bone is present in all affected individuals and may be the only evidence of disease. A congenital heart malformation is present in 75% of individuals with HOS and most commonly involves the septum. Atrial septal defect and ventricular septal defect can vary in number, size, and location. Complex congenital heart malformations can also occur in individuals with HOS. Individuals with HOS with or without a congenital heart malformation are at risk for cardiac conduction disease. While individuals may present at birth with sinus bradycardia and first-degree atrioventricular (AV) block, AV block can progress unpredictably to a higher grade including complete heart block with and without atrial fibrillation.</Attribute>
                <XRef ID="NBK1111" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301290</ID>
                <ID Source="BookShelf">NBK1111</ID>
              </Citation>
              <XRef ID="392" DB="Orphanet" />
              <XRef ID="C0265264" DB="MedGen" />
              <XRef ID="MONDO:0007732" DB="MONDO" />
              <XRef Type="MIM" ID="142900" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1761653" SubmissionDate="2019-04-01" DateLastUpdated="2019-04-21" DateCreated="2019-04-21">
        <ClinVarSubmissionID localKey="ES113|OMIM:142900" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000898370" DateUpdated="2019-04-21" DateCreated="2019-04-21" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-11-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG CNV Guidelines, 2011</Attribute>
          <Citation>
            <ID Source="PubMed">21681106</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Oligo array</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SecondaryFinding">no</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>copy number loss</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="12" innerStart="114791609" innerStop="114793234" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="142900" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5380435</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1761653" TraitType="Disease" MappingType="XRef" MappingValue="142900" MappingRef="OMIM">
        <MedGen CUI="C0265264" Name="Holt-Oram syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

